These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32765584)

  • 1. Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer.
    Wu A; Zhang S; Liu J; Huang Y; Deng W; Shu G; Yin G
    Front Genet; 2020; 11():705. PubMed ID: 32765584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma.
    Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y
    Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
    Front Oncol; 2021; 11():658547. PubMed ID: 34094951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer.
    Zhang J; Wang H; Yuan C; Wu J; Xu J; Chen S; Zhang C; He Y
    Front Cell Dev Biol; 2022; 10():808212. PubMed ID: 35399517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.
    Nurzat Y; Su W; Min P; Li K; Xu H; Zhang Y
    Front Oncol; 2021; 11():751875. PubMed ID: 34660316
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhou Q; Zhang F; He Z; Zuo MZ
    Front Oncol; 2019; 9():161. PubMed ID: 30967995
    [No Abstract]   [Full Text] [Related]  

  • 10. ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining.
    Chen Y; Tian D; Chen X; Tang Z; Li K; Huang Z; Fu Y; Feng Y; Yang Z
    Int J Gen Med; 2021; 14():967-981. PubMed ID: 33790626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.
    Harryman WL; Pond E; Singh P; Little AS; Eschbacher JM; Nagle RB; Cress AE
    Am J Transl Res; 2016; 8(2):940-54. PubMed ID: 27158381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer.
    Ma JJ; Xiang C; Zhu HQ; Bai BL; Wang P; Zhao GA
    Heliyon; 2024 Jan; 10(1):e23163. PubMed ID: 38163190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SOCS family members with prognostic values in human ovarian cancer.
    Yang M; Chen H; Zhou L; Huang X; Su F; Wang P
    Am J Transl Res; 2020; 12(5):1824-1838. PubMed ID: 32509179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
    Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
    Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
    Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
    PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
    Zhou Q; Yang HJ; Zuo MZ; Tao YL
    J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment.
    Jin Y; Lin Q; Fei H; Xue L; Li L; Xi Q; Jiang H
    J Oncol; 2021; 2021():8859554. PubMed ID: 33763130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 20. Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers.
    Gui J; Yang L; Liu J; Li Y; Zou M; Sun C; Huang L; Zhu X; Huang K
    Heliyon; 2024 Jan; 10(2):e24236. PubMed ID: 38293430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.